rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Eric Groen

General Counsel

Company insider

Files Form 4 as: General Counsel, Genelux; General Counsel, Rani Therapeutics Holdings.

In numbers

Trades disclosed
15
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
0
First trade
22 Mar 2022
Last trade
16 Jun 2026
Last filed
18 Jun 2026

Companies traded

Where they are an officer
GNLX GeneluxOfficer · Biotechnology · last 16 Jun 20260 buys · 0 sells
RANI Rani Therapeutics HoldingsOfficer · Biotechnology · last 21 Mar 20240 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
16 Jun 2026filed 18 Jun 2026GNLX GeneluxBiotechnologySEC FORM 4 Code A—233,957 at $0.00filing
16 Jun 2026filed 18 Jun 2026GNLX GeneluxBiotechnologySEC FORM 4 Code A—233,957 at $0.00filing
1 Jul 2025filed 2 Jul 2025GNLX Geneluxoption or derivative · BiotechnologySEC FORM 4 Code A—270,000 at $0.00filing
21 Mar 2024filed 22 Mar 2024RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—323,500 at $0.00filing
16 Dec 2023filed 19 Dec 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—171,500filing
16 Dec 2023filed 19 Dec 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—171,500filing
16 Dec 2023filed 19 Dec 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—43,400filing
16 Dec 2023filed 19 Dec 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—43,400filing
16 Dec 2023filed 19 Dec 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—54,167filing
16 Dec 2023filed 19 Dec 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—54,167filing
27 Mar 2023filed 29 Mar 2023RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—205,800 at $0.00filing
27 Mar 2023filed 29 Mar 2023RANI Rani Therapeutics HoldingsBiotechnologySEC FORM 4 Code A—139,000 at $0.00filing
22 Mar 2023filed 24 Mar 2023RANI Rani Therapeutics HoldingsBiotechnologySEC FORM 4 Code F$15K2,498 at $5.95filing
22 Mar 2022filed 24 Mar 2022RANI Rani Therapeutics Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—74,400 at $0.00filing
22 Mar 2022filed 24 Mar 2022RANI Rani Therapeutics HoldingsBiotechnologySEC FORM 4 Code A—24,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Talat ImranChief Executive Officer · Chief Executive Officer at Rani Therapeutics Holdings, filing Form 4 there in the last year
Alireza JavadiChief Technical Officer · Chief Technical Officer at Rani Therapeutics Holdings, filing Form 4 there in the last year
Joseph CappelloChief Technical Officer · Chief Technical Officer at Genelux, filing Form 4 there in the last year
Thomas ZindrickPresident and CEO · President and CEO at Genelux, filing Form 4 there in the last year
Yong YuChief Scientific Officer · Chief Scientific Officer at Genelux, filing Form 4 there in the last year